Page last updated: 2024-08-21

quinazolines and Necrosis

quinazolines has been researched along with Necrosis in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.41)18.7374
1990's0 (0.00)18.2507
2000's13 (48.15)29.6817
2010's10 (37.04)24.3611
2020's2 (7.41)2.80

Authors

AuthorsStudies
Dai, Y; Geng, X; Gong, J; Liu, D; Ma, Z; Meng, H; Song, G; Song, Z; Yang, T; Zhou, B1
Arimura, A; Fujii, K; Hashiguchi, T; Hayashida, M; Higashi, Y; Kanekura, T1
Cloughesy, TF; Faiq, N; Green, R; Green, S; Hu, J; Lai, A; Mellinghoff, I; Nghiemphu, PL; Yu, A1
Harter, PN; Mittelbronn, M; Pietsch, T; Reuter, D; Ronellenfitsch, MW; Senft, C; Steinbach, JP; Urban, H; Westphal, M; Zeiner, PS1
Azzariti, A; Cocco, T; Ferretta, A; Guida, G; Guida, M; Guida, S; Iacobazzi, RM; Maida, I; Porcelli, L; Quatrale, AE; Sidella, L; Stolfa, DA; Strippoli, S; Tommasi, S1
Abraham, RR; Girotra, M; Jones, J; Klair, JS1
Chang, J; Shi, Y; Su, C; Yang, G; Zhao, L1
Kawabe, J; Ohsaki, Y; Osanai, S; Sasaki, T; Shibukawa, K; Tanno, S1
Babur, M; Shannon, AM; Stratford, IJ; Telfer, BA; Wedge, SR; Williams, KJ1
Hui, RC; Ko, JH; Shih, YC; Yang, CH1
Busch, AM; Cyrus, J; Dmitrovsky, E; Dragnev, KH; Erkmen, CP; Freemantle, SJ; Galimberti, F; Johnstone, D; Kurie, JM; Liu, X; Ma, T; Memoli, V; Nugent, W; Rigas, JR; Seltzer, M; Tsongalis, GJ; Waxman, S1
Ager, E; Chung, E; Duyverman, AM; Eichler, AF; Engelman, JA; Farrar, CT; Fukumura, D; Goel, S; Hiddingh, L; Huang, Y; Incio, J; Jain, RK; Kamoun, W; Kodack, DP; Lussiez, A; Mahmood, S; Snuderl, M; Song, Y; Tannous, BA; Yamashita, H1
Fletcher, EV; Knudson, CM; Love-Homan, L; Martin, SM; Parsons, AD; Simons, AL; Sobhakumari, A; Spitz, DR1
Gao, X; Li, YL; Liu, XX; Ma, XL; Nie, W; Sang, YX; Shen, GB; Shi, HS; Wang, FT; Wei, YQ; Xu, GC1
Hénichart, JP; Mimeault, M; Pommery, N1
Ikejima, T; Onodera, S; Tashiro, S; Wu, LJ; Zhang, Y1
Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL1
Bianco, AR; Bianco, C; Bianco, R; Bunn, P; Ciardiello, F; Cionini, L; D'Armiento, FP; Damiano, V; Melisi, D; Mignogna, C; Raben, D; Tortora, G1
de Waal, R; Heerschap, A; Küsters, B; Leenders, WP; Maass, C; Ruiter, D; Ryan, A; Verrijp, K; Wesseling, P1
Biddle, A; Davis, TH; Desai, NB; Dmitrovsky, E; Dragnev, KH; Hamilton, M; Iwata, KK; Ma, Y; Memoli, N; Memoli, VA; Nugent, WC; Petty, WJ; Rigas, JR1
Lafayette, RA; Rodwell, GE; Troxell, ML1
Figlin, R; Fishbein, MC; Truell, JS1
Ikejima, T; Onodera, S; Tashino, S; Wu, LJ; Yang, J1
Cipák, L; Jantová, S; Kubíková, J; Maliar, T; Mikulásová, M; Rauko, P; Spirková, K; Stankovský, S; Urbancíková, M1
Barak, V; Eshhar, Z; Gavish, Z; Nagler, A; Pines, M; Pinthus, JH; Ramon, J1
Buchanan, JO; Buyniski, JP; Fleming, JS1
Danielsson, B; Kronberg, L1

Trials

3 trial(s) available for quinazolines and Necrosis

ArticleYear
Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study.
    Journal of neuro-oncology, 2017, Volume: 134, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Drug Administration Schedule; Female; Glioblastoma; Humans; Karnofsky Performance Status; Lapatinib; Male; Middle Aged; Necrosis; Pilot Projects; Quinazolines; Temozolomide; Thrombocytopenia; Treatment Outcome

2017
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma.
    Acta neuropathologica communications, 2018, 08-21, Volume: 6, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal, Humanized; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Calcium-Binding Proteins; Cohort Studies; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; ErbB Receptors; Female; Glioblastoma; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Microfilament Proteins; Necrosis; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Ribosomal Protein S6; Signal Transduction; Time Factors; Treatment Outcome; Tumor Suppressor Proteins

2018
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:6

    Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cyclin D1; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Immunoblotting; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Transgenic; Middle Aged; Mouth Mucosa; Mutation; Necrosis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins; Salvage Therapy; Survival Rate; Tetrahydronaphthalenes; Treatment Outcome; Tumor Cells, Cultured

2011

Other Studies

24 other study(ies) available for quinazolines and Necrosis

ArticleYear
Resveratrol improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells in rats with severe acute pancreatitis.
    International immunopharmacology, 2020, Volume: 80

    Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Necrosis; Pancreas; Pancreatitis; Paracrine Communication; Phosphatidylinositol 3-Kinase; Piperidines; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Resveratrol; Severity of Illness Index; Signal Transduction; Taurocholic Acid; Vascular Endothelial Growth Factor A

2020
Anagrelide with low-dose aspirin promptly epithelized ulceronecrotic lesion secondary to essential thrombocythemia.
    The Journal of dermatology, 2020, Volume: 47, Issue:5

    Topics: Aspirin; Bone Marrow; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Janus Kinase 2; Karyotyping; Male; Middle Aged; Mutation; Necrosis; Quinazolines; Re-Epithelialization; Skin; Skin Ulcer; Thrombocythemia, Essential; Toes; Treatment Outcome

2020
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy.
    Journal of translational medicine, 2015, Jan-27, Volume: 13

    Topics: Albumins; Apoptosis; Aurora Kinase B; Cell Line, Tumor; Cell Movement; Cell Nucleus Shape; Cell Proliferation; Cell Shape; Cell Survival; Drug Resistance, Neoplasm; Extracellular Space; Humans; Lactic Acid; Melanoma; Mitosis; Necrosis; Neoplasm Metastasis; Organophosphates; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines

2015
A 'shock-ing' endoscopic finding on esophagogastroduodenoscopy.
    BMJ case reports, 2015, Feb-09, Volume: 2015

    Topics: Adenocarcinoma; Antineoplastic Agents; Endoscopy, Digestive System; Erlotinib Hydrochloride; Esophagus; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Multiple Organ Failure; Necrosis; Quinazolines

2015
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
    Journal of nanobiotechnology, 2015, Sep-22, Volume: 13

    Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Intracellular Space; Nanoparticles; Necrosis; Quinazolines

2015
Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts.
    International journal of oncology, 2008, Volume: 33, Issue:3

    Topics: Animals; Apoptosis; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice; Necrosis; Neovascularization, Pathologic; Piperidines; Protein Kinase Inhibitors; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2008
Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts.
    The British journal of radiology, 2008, Volume: 81 Spec No 1

    Topics: Animals; Apoptosis; Carcinoma; Combined Modality Therapy; Female; Lung Neoplasms; Mice; Mice, Nude; Necrosis; Quinazolines; Vascular Endothelial Growth Factor A

2008
Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7

    Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis

2011
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Nov-06, Volume: 109, Issue:45

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Brain Neoplasms; Breast Neoplasms; Cell Death; Cell Proliferation; Diagnostic Imaging; Disease Models, Animal; Female; Gene Amplification; Humans; Killer Cells, Natural; Lapatinib; Mice; Molecular Targeted Therapy; Necrosis; Neovascularization, Pathologic; Quinazolines; Receptor, ErbB-2; Receptors, Vascular Endothelial Growth Factor; Survival Analysis; Trastuzumab; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Auranofin; Buthionine Sulfoximine; Carcinoma, Squamous Cell; Catalase; Cell Line, Tumor; Cell Survival; Drug Synergism; Erlotinib Hydrochloride; Female; Gene Knockdown Techniques; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Necrosis; Oxidation-Reduction; Oxidative Stress; Peroxiredoxins; Quinazolines; RNA, Small Interfering; Thioredoxin-Disulfide Reductase; Thioredoxins; Xenograft Model Antitumor Assays

2012
Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26.
    Clinical and experimental medicine, 2014, Volume: 14, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Female; Histocytochemistry; Hyperthermia, Induced; Immunohistochemistry; Mice, Inbred BALB C; Necrosis; Platelet Endothelial Cell Adhesion Molecule-1; Quinazolines; Thiadiazoles; Treatment Outcome

2014
Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines.
    International journal of cancer, 2003, Aug-10, Volume: 106, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Cell Division; Cell Separation; Ceramides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Humans; Male; Membrane Potentials; Mitochondria; Necrosis; Prostatic Neoplasms; Protease Inhibitors; Quinazolines; Tumor Cells, Cultured

2003
Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:1

    Topics: Apoptosis; Caspase 3; Caspase 8; Caspases; Cell Cycle; DNA Fragmentation; Dose-Response Relationship, Drug; Evodia; HeLa Cells; Humans; Melanoma; Mitogen-Activated Protein Kinases; Necrosis; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Plants, Medicinal; Quinazolines; Time Factors

2004
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7

    Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley

2004
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:8

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Endothelium, Vascular; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Female; Gefitinib; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Organophosphorus Compounds; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Time Factors

2004
Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 1

    Topics: Angiogenesis Inhibitors; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Melanoma; Mice; Mice, Inbred BALB C; Necrosis; Neoplasm Metastasis; Neovascularization, Pathologic; Oligonucleotides, Antisense; Phenotype; Piperidines; Placebos; Quinazolines; RNA; Transfection; Treatment Outcome; Vascular Endothelial Growth Factor A

2004
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22

    Topics: Biomarkers, Tumor; Bronchi; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Cyclin D1; DNA; Dose-Response Relationship, Drug; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Exons; G1 Phase; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Kinetics; Luciferases; Necrosis; Neoplasms; Quinazolines; Sequence Analysis, DNA; Time Factors; Transcriptional Activation

2004
Renal tubular injury associated with anagrelide use.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:5

    Topics: Humans; Kidney Tubules; Male; Middle Aged; Necrosis; Quinazolines

2005
Myocarditis temporally related to the use of gefitinib (Iressa).
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:8

    Topics: Acute Disease; Aged; Antineoplastic Agents; Drug Hypersensitivity; Fatal Outcome; Gefitinib; Humans; Male; Myocarditis; Myocytes, Cardiac; Necrosis; Quinazolines

2005
Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells.
    Free radical research, 2008, Volume: 42, Issue:5

    Topics: Acridine Orange; Apoptosis; Autophagy; bcl-X Protein; Cadaverine; Cell Nucleus; Cell Survival; HeLa Cells; Humans; Mitochondria; Necrosis; Nitric Oxide; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Reactive Oxygen Species

2008
Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton.
    Neoplasma, 2001, Volume: 48, Issue:1

    Topics: Animals; CHO Cells; Cricetinae; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Leukemia; Melanoma; Mice; Mutagenicity Tests; Necrosis; Protease Inhibitors; Quinazolines; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured

2001
Growth inhibition of prostate cancer xenografts by halofuginone.
    The Prostate, 2002, May-01, Volume: 51, Issue:2

    Topics: Adenocarcinoma; Administration, Oral; Androgens; Animals; Antineoplastic Agents; Apoptosis; Collagen Type I; Disease Progression; DNA, Neoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; In Situ Hybridization; Injections, Intraperitoneal; Male; Mice; Mice, SCID; Necrosis; Neovascularization, Pathologic; Phenotype; Piperidines; Prostatic Neoplasms; Quinazolines; Quinazolinones

2002
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
    European journal of pharmacology, 1976, Volume: 40, Issue:1

    Topics: Animals; Aspirin; Blood Pressure; Disease Models, Animal; Dogs; Epinephrine; Female; Imidazoles; Male; Myocardial Infarction; Necrosis; Phenoxybenzamine; Platelet Aggregation; Propranolol; Quinazolines

1976
Studies on the medicinal chemistry of oxoquinazolines. II. Synthesis and local anaesthetic activity of homologous derivatives of 1,2,3,4-tetrahydro-2,4-dioxoquinazoline and 3,4-dihydro-4-oxoquinazoline.
    Acta pharmaceutica Suecica, 1969, Volume: 6, Issue:3

    Topics: Anesthetics, Local; Animals; Anura; Chemical Phenomena; Chemistry; Cornea; Guinea Pigs; In Vitro Techniques; Lidocaine; Mice; Necrosis; Quinazolines; Rabbits; Sciatic Nerve; Tremor

1969